Frontlight ResearchEarly access
WithdrawnNo phase
A Randomized Controlled Trial for Partial Knee Arthroplasty
Key facts
- Who runs it
- Zimmer Biomet
- Where
- Jackson, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- Jun 2023
- Expected to end
- Dec 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Persona Partial Knee System
- Record updated
- 5 June 2023
- Why it stopped
- Relaunch at later date with updated product.
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (17)Hide the full registry criteria
Who can take part
- Patient meets the approved indications for use in accordance with product labeling for both the Persona Partial Knee System and the ROSA® Partial Knee System
- Body mass index ≤40 kg/m2
- Patient is of legal age and skeletally mature
- Patient is willing and able to provide informed consent
- Patient is willing to be randomized into one of two study groups of UKA performed using ROSA® and UKA using Conventional Instrumentation
- Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol
- Patient qualifies for primary UKA based on investigator's clinical judgement and has an intact anterior cruciate ligament
- Independent of study participation, patient is a candidate for the commercially available Persona Partial Knee System
Who cannot take part
- Prior ACL Repair
- Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation
- Patient has a condition which would, in the judgement of the investigator, place the patient at undue risk or interfere with the conduct of the study
- Independent of study participation, patient meets any of the contraindications for use in accordance with product labeling of the Persona Partial Knee System and/or the ROSA® Partial Knee System
- Orthopaedic procedure or pain management study of any joint within the last or next 6 months; furthermore, bilateral enrollment is excluded in this study
- Moderate to severe patello-femoral arthritis, that in the opinion of the investigator, would require patella-femoral arthroplasty
- Patient is unwilling to sign the Informed Consent
- Would, in the investigator's opinion, be unwilling or unable to comply with the postoperative care instructions or study follow-up schedule
- Patient is considered a member of a protected/vulnerable population (Pregnant, prisoner, mentally incompetent, etc.)
Where in United States
- Mississippi Sports Medicine and Orthopaedic CenterJackson, United States
About the trial
What the trial wants to find out
This is a prospective, multi-center, two-arm, randomized, controlled post-market study to evaluate and compare the clinical accuracy of component placement in robotic-assisted UKA and that of traditional methods.
The 2 groups in the trial
- Robotic-Assisted UKAExisting treatment, for comparison
Randomized participant will receive UKA via the ROSA Partial Knee System.
Treatment: Persona Partial Knee System
- Traditional/Conventional UKAExisting treatment, for comparison
Randomized participant will receive the UKA via Conventional/Traditional UKA Methods.
Treatment: Persona Partial Knee System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Post-Market, Multicenter, Randomized Controlled Trial of the ROSA® Partial Knee System for Unicompartmental Knee Arthroplasty
- Record updated
- 5 June 2023